BioLife4D Corporation (SAVU)

BioLife4D Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2021	2020
Cash & Equivalents	0.93	0.33
Cash & Cash Equivalents	0.93	0.33
Cash Growth	180.07%	-
Other Current Assets	0.03	0.01
Total Current Assets	0.96	0.34
Property, Plant & Equipment	0.01	0.01
Other Long-Term Assets	0.02	0
Total Long-Term Assets	0.02	0.02
Total Assets	0.98	0.36
Accounts Payable	0	-
Other Current Liabilities	0.08	0.03
Total Current Liabilities	0.09	0.03
Long-Term Debt	0.75	0.9
Other Long-Term Liabilities	0.14	0.09
Total Long-Term Liabilities	0.88	1
Total Liabilities	0.97	1.02
Total Debt	0.75	0.9
Debt Growth	-17.66%	-
Retained Earnings	-6.61	-5.11
Shareholders' Equity	0.01	-0.66
Net Cash / Debt	0.19	-0.57
Working Capital	0.87	0.32

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).